SCHEMBL6511964

SCHEMBL6511964

Cc1ccc(C(=O)Nc2ccc3sc(C(=O)NO)cc3c2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 12/20 0.76
NPC1 O15118 5/20 0.57
RAB9A P51151 5/20 0.57
HDAC6 Q9UBN7 3/20 0.56
HDAC3 O15379 2/20 0.56
HDAC4 P56524 2/20 0.56
HDAC7 Q8WUI4 2/20 0.56
HDAC2 Q92769 2/20 0.56
HDAC10 Q969S8 2/20 0.56
HDAC11 Q96DB2 2/20 0.56
HDAC8 Q9BY41 2/20 0.56
HDAC9 Q9UKV0 2/20 0.56
HDAC5 Q9UQL6 2/20 0.56
MAPT P10636 2/20 0.51
ALDH1A1 P00352 1/20 0.51
NFKB1 P19838 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MEN1 O00255 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22718544 0.88 HDAC1 (0.74) HDAC1HDAC6HDAC3HDAC11HDAC8
SCHEMBL6509553 0.88 HDAC1 (0.78) HDAC1RAB9AHDAC6HDAC3HDAC4
SCHEMBL1886609 0.86 HDAC1 (1.00) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL6508495 0.86 HDAC1 (0.75) HDAC1NPC1RAB9AHDAC6HDAC3
SCHEMBL6508477 0.86 HDAC1 (0.71) HDAC1NPC1RAB9AHDAC6ALDH1A1
SCHEMBL6514838 0.86 HDAC1 (0.71) HDAC1NPC1RAB9AHDAC6HDAC3
SCHEMBL6509337 0.86 HDAC1 (0.71) HDAC1NPC1RAB9AHDAC6HDAC3
SCHEMBL6514967 0.86 HDAC1 (0.74) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL1894177 0.85 HDAC1 (0.85) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL6512704 0.84 HDAC1 (0.76) HDAC1RAB9AHDAC6HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005066151-A2 HISTONE DEACETYLASE INHIBITORS TAKEDA SAN DIEGO, INC. (US) 2005-07-21 WO claimed
US-20050137234-A1 Histone deacetylase inhibitors SYRRX, INC. 2005-06-23 US claimed
WO-2005066151-A2 HISTONE DEACETYLASE INHIBITORS TAKEDA SAN DIEGO, INC. (US) 2005-07-21 WO disclosed
US-20050137234-A1 Histone deacetylase inhibitors SYRRX, INC. 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137234-A1 Histone deacetylase inhibitors HDAC1, HDAC5, HDAC11 HDAC1 1/4885NPC1 1868/4885RAB9A 3382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.